Thinking beyond medication

Frontier Business. Providing more holistic care. Scouting new ideas. Enabling novel technologies. Connecting the best scientific minds and collaborators.

We are pioneering new frontiers in healthcare that go beyond medication.

Today, we are surging ahead to achieve that promise. Through joint research and development programs, we are turning ideas and concepts into real solutions and products – with a focus on mental health and active aging – to provide people with more complete support.

Empowering people with more choices

Mental wellbeing is important. It affects our ability to think and feel. Maintaining our mental health is key to active aging and for living a happy life. For people with mental or age-related cognitive disorders, recovering and maintaining mental wellbeing is even more important.

Medication is considered, for the most part, the cornerstone to managing mental health conditions. But pharmacotherapy alone may not be enough in certain instances.

Empowering people with more flexible and convenient choices may create a better solution that allows them to access the right therapy at the right time while reducing lingering stigmas and loneliness.

By developing new technologies and other innovations, we are providing people with broader solutions to achieve better access to care and comprehensive management of their conditions.

  • Patient-driven

    Flexible, personalized solutions that go beyond medication to improve access to care, offer additional options and diminish stigmas and isolation

  • Science-minded

    Leveraging our expertise in developing medications that meaningfully enhance mental health and active aging

  • Solution-focused

    Scouting for ideas, connecting the best scientific minds and collaborating on cutting-edge innovations to pioneer new frontiers in healthcare

  • Visionary

    Redefining the relationship between pharma and total wellbeing to revolutionize supportive care through empowering and convenient choices

  • Global

    Exploring and facilitating opportunities for exciting collaboration and inspiring business across the geographic border, starting from US, Japan, and China.

Press releases

{{post.post_title}}

{{formatDate(post.post_date, 'Mstr DD, YYYY')}}

Our leadership across the globe

COVID-19 has introduced a variety of unprecedented challenges to healthcare, but we have an opportunity to build momentum for real behavioral change. Not just adopt a new reality, but to fundamentally lead healthier lives, even during a time of pandemic. At Frontier Business, we recognize now more than ever the importance of coming up with truly innovative, beyond-the-pill solutions to help support all aspects of your wellbeing.

Hiroyuki Baba, Senior Executive Officer in charge of Frontier Business

Leadership

  • Hiroyuki Baba | MBA

    Senior Executive Officer in charge of Frontier Business Office
    Sumitomo Dainippon Pharma Co., Ltd.

  • Takehiko Nomura | PhD

    Senior Director, Frontier Business Office; Head of Global Frontier Business Development
    Sumitomo Dainippon Pharma Co., Ltd.

Management

  • Bobby (Tetsuya) Uyama | LL.M.

    Senior Director, Frontier Business Office
    Sumitomo Dainippon Pharma America, Inc.

  • Yasushi Ochiai | MS

    Planning and Development Officer, Frontier Business Office
    Sumitomo Dainippon Pharma Co., Ltd.

  • Yukako Nishimaki

    Business Planning Officer, Frontier Business Office
    Sumitomo Dainippon Pharma Co., Ltd.

  • Krys (Christina) Zaluski | MA

    Director, Frontier Business Office
    Sumitomo Dainippon Pharma America, Inc.

Contact us

  • Tokyo, JAPAN

    Frontier Business Office
    Sumitomo Dainippon Pharma Co., Ltd.
    13-1, Kyobashi 1-chome, Chuo-ku,
    Tokyo 104-8356, Japan

  • Boston, USA

    Frontier Business Office
    Sumitomo Dainippon Pharma America, Inc.
    640 Memorial Drive, Cambridge, MA, USA 02139